A Phase 2/3 interventional study of Oxygen and Air in Hyperbaric, Diving Medicine and Decompression Sickness, sponsored by Göteborg University. Completed at 2 sites in Sweden. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-27.
Sponsored by Göteborg University · Phase 2/3, Interventional, and Prevention
Primary objective:
Secondary objective:
Tertiary objective:
This is a prospective, double blinded, randomized, cross-over study in Sweden. The study was performed in two different sets, each containing standardized dives in a wet hyperbaric chamber. The dives included movement on depth.
In each study set 16-32 professional divers performed no-decompression dives to a depth of 42 metres of seawater (msw). The gas used during the dives was compressed air.
After surfacing the divers breathed either normobaric oxygen or normobaric air on a demand mask. Timing of oxygen/air-breathing differed between study sets. The content of breathing gas was unknown to both divers and examining personnel.
Immediately post dive the divers were assessed using either transthoracic doppler ultrasound (TTD) or transthoracic 2-D ultrasound (TTE) to determine VGE load, time to VGE detection and VGE duration.
Signs of DCS were actively sought.
TTD measurements were done every five minutes during the first 30 minutes, thereafter every 15 minutes during 90 minutes.
TTE was performed every 30 minutes, using an apical 4-chamber view.
Blood samples were obtained pre-dive, 30-45 minutes post-dive and 120 minutes post-dive.
Set 1: 16 divers, divided into two equal groups (A and B). Dive to 42 msw during 10 min with a safety stop at five msw during three min. Immediately post dive breathing of oxygen (group A) or air (group B) during 30 min. VGE load, time to VGE detection and VGE duration is recorded. Blood samples were obtained pre-dive and 30 and 120 minutes post-dive. After 48 hours, the dives were repeated with switched gases between the groups.
Set 2: 32 divers, divided into two equal groups (A and B). Dive to 42 msw during 10 min with a safety stop at five msw during three min. Fifteen minutes post dive breathing of oxygen (group A) or air (group B) during 30 min. VGE load, time to VGE detection and VGE duration is recorded. Blood samples were obtained pre-dive and 45 and 120 minutes post-dive, from the first 16 divers. After 48 hours, the dives were repeated with switched gases between the groups.
Two further planned sets with repeated diving and shorter duration of oxygen/air-breathing were never carried through.
AE including SAE will be recorded during the study. DCS may be considered either an AE or SAE depending on severity. Ongoing AE and SAE will be followed up.
Exclusion Criteria:
Normobaric air breathing
Other: Air
Normobaric oxygen breathing
Drug: Oxygen
Venous gas emboli
Kisman-Masurel grading
Time frame: 120 minutes
Inflammatory activity and endothelial dysfunction
E.g. VCAM-1, ICAM-1
Time frame: 120 minutes/ 48 hours
Decompression sickness
Clinical diagnosis
Time frame: 24 hours
Markers of central nervous system injury
E.g. GFAP, Tau, NfL, UCHL-1
Time frame: 120 minutes/ 48 hours
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Göteborg University